2018 annual financial data
BioCryst Pharmaceuticals 2018 Operating margin
BioCryst Pharmaceuticals 2018 operating margin with verified reported values.
Direct answer
Operating margin was -456.2%.
Operating income was -94,220,000 USD and net income was -101,252,000 USD.
Operating cash flow was -92,565,000 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,653,000 USD
- Operating income
- -94,220,000 USD
- Net income
- -101,252,000 USD
- Operating cash flow
- -92,565,000 USD